Given these connections between mitochondrial morphology, adipokines, obesity, and cancer, it will be important to assess the effects of SH‐BC‐893 on mitochondria in tumors and its effectiveness in tumor models that are sensitive to a HFD and/or leptin and insulin levels. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.